Skip to main content
. 2013 Jan 15;108(1):99–106. doi: 10.1038/bjc.2012.494

Table 4. Differential levels of CCL15 in various groups.

Groups CCL15 (pgml−1)
Cancer
B-related HCC (55) 26.6±1.2
C-related HCC (25) 23.9±3.1a
Lung cancer (15) 4.3±1.7b
Gastric cancer (15) 4.1±0.5c
Carcinoma of gallbladder (15) 3.6±1.5d
Benign diseases (65) 2.0±0.9e,f
Healthy controls (60) 1.2±0.1g

Abbreviations: CCL15=C-C motif chemokine 15; HCC=hepatocellular carcinoma.

a

Showed P>0.05 between B-related HCC and C-related HCC.

b

Showed P<0.05 between B-related HCC and lung cancer.

c

Showed P<0.05 between B-related HCC and gastric cancer.

d

Showed P<0.05 between B-related HCC and carcinoma of gallbladder.

e

Showed P<0.05 between B-related HCC and benign diseases.

f

Showed P>0.05 between benign diseases and healthy controls.

g

Showed P<0.05 between B-related HCC and healthy controls.